AEON Biopharma(AEON) Stock Price Today

US Stock MarketDetailed Quotes

AEON Biopharma (AEON)

Watchlist

0.9784
-0.0066-0.67%

Close Apr 1 15:59 ET

0.9683
-0.0101-1.03%

Pre 05:16 ET

24.76MMarket Cap-0.25P/E (TTM)

AEON Stock Chart

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

AEON Orderflow

Unit: --

AEON Orderflow Trend

IntradayDayWeekMonth

No Data

AEON Biopharma (AEON) News

AEON Biopharma | 10-K: Annual report
SECMar 30 18:13 ET · Announcements
Express News | AEON Biopharma Q4 EPS $(3.72)
BenzingaMar 30 16:34 ET
Express News | AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for Abp-450 Biosimilar Program
ReutersMar 30 16:05 ET
Express News | AEON Biopharma Inc - to Request Bpd Type 2B Meeting With FDA in 2026 for Abp-450 Biosimilar
ReutersMar 25 08:01 ET
Express News | AEON Biopharma Inc - FDA Supports AEON's Analytical Similarity Strategy Under 351(K) Biosimilar Pathway
ReutersMar 25 08:01 ET
AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program
GlobeNewswireMar 25 08:00 ET

AEON Biopharma (AEON) Stock Forum

DrJaguar8

Mar 25 20:02

NEWS

$AEON Biopharma (AEON.US)$
AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program
Wednesday, 25th March at 8:00 am
FDA provided constructive feedback on Company's analytical similarity strategy under the 351(k) biosimilar pathway
Company continues to execute its analytical program and plans to request a BPD Type 2b meeting with the FDA in 2026 to discuss next steps in the development of ABP-450 as a biosimilar to BOTOX®
IRVINE, Calif., M...

Trytosaveabit

Jan 22 06:32

New 8K

$AEON Biopharma (AEON.US)$ PRESS RELEASE
AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions
- AEON confirmed that earlier today it held its BPD Type 2a Meeting with the FDA, in ** with prior guidance, and is now awaiting official meeting minutes -
- Separately, AEON shareholders today voted in favor of the proposals required to complete the transactions announced in November, including the consummation of the PIPE financing and the re...

DrJaguar8

Jan 22 05:08

NEWS

$AEON Biopharma (AEON.US)$
AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions
by Globe Newswire
Follow
- AEON confirmed that earlier today it held its BPD Type 2a Meeting with the FDA, in ** with prior guidance, and is now awaiting official meeting minutes